Ekso Bionics (NASDAQ:EKSO) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Ekso Bionics (NASDAQ:EKSO) announced its quarterly earnings results on Monday. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.02), Yahoo Finance reports. The firm had revenue of $4.13 million for the quarter, compared to analyst estimates of $6.00 million. Ekso Bionics had a negative return on equity of 92.08% and a negative net margin of 68.41%. During the same quarter in the prior year, the business earned ($0.24) EPS.

Ekso Bionics Stock Performance

Shares of EKSO stock opened at $0.90 on Tuesday. The firm has a 50 day moving average of $1.11 and a two-hundred day moving average of $1.15. The stock has a market capitalization of $16.36 million, a PE ratio of -1.16 and a beta of 1.45. The company has a quick ratio of 1.77, a current ratio of 2.42 and a debt-to-equity ratio of 0.36. Ekso Bionics has a 52 week low of $0.83 and a 52 week high of $3.13.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. HC Wainwright reduced their price target on shares of Ekso Bionics from $10.00 to $9.00 and set a “buy” rating on the stock in a research note on Tuesday. StockNews.com initiated coverage on Ekso Bionics in a research report on Saturday. They issued a “hold” rating for the company.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.